Results for "drug resistance"67

Showing 51–67 of 67 documents

Sorted by hybrid relevance (keyword + semantic via RRF)

Guideline2025-12
Monitoring the dissemination, use and impact of WHO guidelines and other normative products: 10 case studies
World Health Organization
…culosis, HIV, nutrition, reproductive health, antimicrobial resistance, road safety and pharmaceutical regulation. The case studies describe monitoring systems, indicators, databases, dashboards, surveys and country review processes used to assess dissemination, policy uptake, i…
GuidelineLTBI2018-02
Latent tuberculosis infection: updated and consolidated guidelines for programmatic management: annex 2: evidence-to-decision and GRADE tables
World Health Organization
GuidelineLTBI

GuidelineMDR-TB2024-08Related document (Main document):

WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment: web annex A: pharmacokinetics modelling and simulation studies for dosages of 6Lfx and 3HP

World Health Organization

…thods, datasets and pharmacokinetic models used to simulate drug exposure across paediatric populations from high tuberculosis burden settings. For levofloxacin, simulations were based on population pharmacokinetic models and demographic datasets from countries with high multidru…

GuidelineLTBI2025-12Related document (Main document):

WHO updated recommendations on HIV clinical management: recommendations for a public health approach: web annex: supporting information

World Health Organization

…ghly effective for second-line therapy, while selected dual-drug regimens show comparable efficacy in specific populations. Long-acting injectable therapies demonstrate similar virological outcomes but raise concerns regarding resistance and adverse events. Evidence highlights t…

GuidelineMDR-TB2022-05

WHO operational handbook on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment

World Health Organization

…ce for implementing WHO recommendations on the treatment of drug-susceptible tuberculosis (DS-TB). Developed within the framework of the End TB Strategy, the publication complements the WHO consolidated guidelines on tuberculosis by translating evidence-based policy recommendatio…

Results for "drug resistance"67

Monitoring the dissemination, use and impact of WHO guidelines and other normative products: 10 case studies

Latent tuberculosis infection: updated and consolidated guidelines for programmatic management: annex 2: evidence-to-decision and GRADE tables

Latent tuberculosis infection: updated and consolidated guidelines for programmatic management

Latent tuberculosis infection: updated and consolidated guidelines for programmatic management: annex 3: values and preferences for the management of latent tuberculosis infection: survey of populations affected by the recommendations

Report of a WHO expert consultation on dosing to enable implementation of treatment recommendations in the WHO consolidated guidelines on the management of TB in children and adolescents

Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for dots-plus

WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment: web annex A: pharmacokinetics modelling and simulation studies for dosages of 6Lfx and 3HP

Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB) / writing committee: Scientific Panel of the WHO Working Group on DOTS-Plus for MDR-TB

Ethambutol efficacy and toxicity : literature review and recommendations for daily and intermittent dosage in children

Guidelines for workplace TB control activities : the contribution of workplace TB control activities to TB control in the community / Dermot Maher ... [et al.] ; with Phyllis Gabriel, Sophie Kisting, Pierre-Yves Norval

WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment: web annexes

Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (2016), 28 - 29 June 2016, Geneva, Switzerland

WHO updated recommendations on HIV clinical management: recommendations for a public health approach: web annex: supporting information

WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment

WHO operational handbook on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment